is retatrutide or tirzepatide better vs. Tirzepatide: The New Contender vs. the Current Leader Retatrutide vs Tirzepatide — Key – Retatrutide vs Tirzepatide: Key Differences

The SOUL cardiovascular outcomes trial (CVOT) demonstrated a 14% relative reduction in risk of MACE in patients treated with Rybelsus 14 mg orally once daily for approximately 5 years compared to those who received placebo

3A) could be reduced greatly by the antagonist exendin(939), Pro(3)GIP, and SC203972

What the NAD+ Research Tells Us Scientific studies show that boosting NAD

Press Releases Oops

This article examines the evidence for visceral fat reduction with GLP-1 therapy, the mechanisms involved, and clinical implications for patients with central obesity and cardiometabolic disease

The compound is not approved for therapeutic use anywhere in the world